Skip to content

Results Wide and Conical Neck EVAR Procedures

The Performance of the Endurant Endoprosthesis in an Infrarenal Aortic Aneurysm With a Wide or Conical Shaped Infrarenal Neck Anatomy

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06972095
Acronym
Endurant_WCN
Enrollment
268
Registered
2025-05-14
Start date
2021-03-23
Completion date
2025-04-17
Last updated
2026-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal Aortic Aneurysm

Keywords

abdominal aortic aneurysm, EVAR, wide neck, conical neck, hostile neck

Brief summary

Retrospective single centre observational cohort study of patients who underwent an elective infrarenal abdominal aortic aneurysm repair, from January 2011 to January 2020.

Detailed description

Objective: To evaluate the performance of the Endurant endoprothesis in patients with a wide or conical shaped neck anatomy after elective abdominal aortic aneurysm repair. Inclusion: Patients who underwent elective infrarenal abdominal aortic aneurysm repair with the Endurant endograft between January 2011 until January 2020 in Rijnstate, Arnhem, the Netherlands. Primary endpoint: Freedom from reinterventions at one year. Secondary outcomes: * Endoleaks * Aneurysm sac growth * Aneurysm rupture * Stent migration * AAA-related mortality * All-cause mortality * Procedural time * 30-day complications * Renal dysfunction/renal occlusion * Proximal fixation failure

Interventions

PROCEDUREEVAR

endovascular repair of the AAA with the endurant stent graft

Sponsors

Rijnstate Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

All patients with an elective infrarenal endovascular abdominal aortic aneurysm repair with the Endurant endoprothesis between January 2011 till January 2020 in the Rijnstate hospital, Arnhem, the Netherlands.

Exclusion criteria

* emergency/rupture procedures * objection use of data for research * other prosthesis used for EVAR

Design outcomes

Primary

MeasureTime frameDescription
Freedom from reinterventions at one yearone yearreintervention-free survival will be evaulated using kaplan meier method

Secondary

MeasureTime frameDescription
Freedom from reinterventions throughout follow-up (up to ten years)10 yearsReintervention-free survival throughout all available follow-up will be evaluated using kaplan-meier methods
Number of endoleaks10 year follow-upAll endoleaks will be registered throughout follow-up and will be presented by type of endoleak.
the number of patients showing aneurysm sac growth10 year follow-upSac growth is defined as growth over 5 mm and will be presented for 1 year follow-up, 5 years follow-up and 10 year follow-up
the number of patients with an aneurysm rupture during follow-up10 year follow-upall ruptures that occur will be registered including outcome (death or successful repair)
the number of patients showing stent migration10 year follow-upstent migration will be documented in mm and will be presented for 1 year follow-up, 5 years follow-up and 10 year follow-up
Number of patients with AAA related mortality10 year follow-upAll deaths related to the AAA will be documented
the number of patients showing proximal fixation failure10 year follow-upproximal fixation failure is defined as yes if type 1 endoleak or stent migration or aneurysm sac growth will occur and will be presented for 1 year follow-up, 5 years follow-up and 10 year follow-up
All-cause mortality10 year follow-upall deaths will be registered regardless their cause
The number of patients with 30-day complications30 daysAll complications during the first 30 days will be registered related to the procedure and will be listed for the different types of complications
The number of patients with renal dysfunction/renal occlusion10 year follow-upall clinical relevant declines in renal function will be documented, including renal artery stenosis or occlusion

Countries

Netherlands

Contacts

PRINCIPAL_INVESTIGATORM.M.P.J. Reijnen Vascular Surgeon, Prof. Dr.

Rijnstate

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026